Basic Information
ACT Genomics Holdings Company Limited is an Asian genomics company focused on precision oncology, with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand, and the United Kingdom. ACT offers a range of genomic testing services for major solid tumor types to help guide clinicians' treatment decisions. It also provides biomarker discovery and companion diagnostic development services for academic and industry partners.
ACT Genomics Holdings Company Limited
Singapore
unclear
June 12, 2019
--
--

